| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Principal payments of finance lease | 43,671 | - |
| Payment of placement agent fees and offering costs | 679,337 | - |
| Payment of net liabilities assumed in reverse recapitalization with kintara | 550,000 | 550,000 |
| Net cash flows from financing activities | 13,420,877 | 8,149,741 |
| Net change in cash and cash equivalents | -9,959,762 | -4,144,354 |
| Cash and cash equivalents at beginning of period | 12,657,178 | - |
| Cash and cash equivalents at end of period | 2,697,416 | - |
TuHURA Biosciences, Inc. NV (HURA)
TuHURA Biosciences, Inc. NV (HURA)